CARLSBAD, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Alphatec Holdings, Inc. , a spinal device company that provides customized products and a broad line of spine fusion and dynamic stabilization surgical implants, announced today that it will be presenting at the First Albany Capital 2nd Annual Orthopedic conference on February 13, 2007, at 8:50 a.m. Pacific time, followed by a breakout session at 9:10 a.m. The conference is being held at the Marina Village Conference Center in San Diego, California.
John Foster, Chairman, President and Chief Executive Officer of Alphatec, stated, “This conference will be our first opportunity to present the Alphatec story to investors following the signing of the License Agreements with Scient’x S.A., which we announced last week. We look forward to speaking with investors about the ways in which our broadened product line will enable our company to continue its rapid growth and extend its leadership position in the spinal implant market.”
On the evening of February 13, following the conclusion of the First Albany conference, Alphatec will be hosting a tour of its manufacturing facility in Carlsbad, California, followed by a casual dinner with senior management. Round-trip transportation from San Diego to Carlsbad will be provided by Alphatec. Interested investors attending the First Albany conference or the American Association of Orthopedic Surgeons (AAOS) conference also being held in San Diego should contact Andreas Marathovouniotis of Noonan Russo at 212-845-4253 by Friday, February 2, for additional information and to reserve a place.
“Our ability to manufacture products in-house provides Alphatec with a significant competitive advantage by enabling us to quickly manufacture and provide unique products to surgeons when they are needed,” commented Mr. Foster. “We encourage investors to take advantage of our proximity to San Diego and join us for an informative and enjoyable dinner and tour of our state-of-the-art facility.”
About Alphatec
Alphatec is a medical device company focused on the design, development, manufacturing and marketing of products for the surgical treatment of spine disorders. Alphatec’s principal product offerings are primarily focused on the U.S. spine fusion market, which is estimated to approach $3 billion in 2007, through its wholly-owned subsidiary, Alphatec Spine, Inc., and include a variety of spinal implant products and systems comprised of components such as spine screws, spinal spacers, and plates that offer multiple solutions to address patients’ needs. In addition to Alphatec’s U.S. presence, it also participates in the Japanese spine fusion and orthopedic trauma markets through its subsidiary, Alphatec Pacific, Inc. Alphatec’s mission is to be a value-based leader in the spinal device market by providing unmatched service to and taking scientific direction from its surgeon customers. Alphatec does so through its unique in-house manufacturing facility in Carlsbad, California, that allows us to respond quickly to surgeon needs and to customize innovative products needed for spine fusion surgery.
Forward Looking Statements
This press release may contain forward-looking statements that involve risks and uncertainty, including statements that the company believes (i) the ALIF cage system is ground-breaking, (ii) that its broadened product line will appeal to growing numbers of spine surgeons across the U.S. while at the same time creating additional pull-through demand for the company’s existing products, (iii) that Alphatec will continue to develop, acquire and license leading technologies in the spine industry in pursuit of its growth strategy. Such statements are based on management’s current expectations and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec cautions investors that there can be no assurance that actual results or business conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors, including, but not limited to, the following: Alphatec’s ability to maintain its level of previously reported sales growth, Alphatec’s ability to manage, develop and expand its spine fusion business in the United States and Japan, Alphatec’s ability to expand and maintain a successful sales and marketing organization, continuation of favorable third party payor reimbursement for procedures performed using our products, unanticipated expenses or liabilities or other adverse events affecting cash flow or Alphatec’s ability to achieve profitability, uncertainty of additional funding, uncertainty of success in developing any new products or acquiring or licensing leading technologies in the spine industry on terms acceptable to the company, failure to successfully introduce and develop new products, including products related to license agreements, failure to obtain FDA clearance or approval for particular devices, Alphatec’s ability to compete with other competing products and with emerging new technologies within and outside of spinal fusion, product liability exposure, patent infringement claims and claims related to our intellectual property. Please refer to the risks detailed in Alphatec’s quarterly report on Form 10-Q for the quarter ended September 30, 2006. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, unless required by law.
Contact: Alphatec Spine, Inc. Steven Yasbek Chief Financial Officer (760) 431-9286 SYasbek@alphatecspine.com Noonan Russo Matthew Haines (212) 845-4235 Matthew.Haines@eurorscg.com
Alphatec Holdings, Inc.
CONTACT: Steven Yasbek, Chief Financial Officer, Alphatec Spine, Inc.,+1-760-431-9286, SYasbek@alphatecspine.com; or Matthew Haines, NoonanRusso, +1-212-845-4235, Matthew.Haines@eurorscg.com
